Internal medicine

Lymphovascular invasion

Meta-analysis

Cancer

Oncology

Metastasis

Endometrial cancer

Adjuvant therapy

Multivariate analysis

Confidence interval

Medicine

Gynecologic Oncology

The 2020 ESGO/ESTRO/ESP guidelines stratify the prognosis of endometrial carcinoma (EC) patients combining The Cancer Genome ATLAS (TCGA) molecular signature and pathological factors, including lymphovascular space invasion (LVSI). However, little is known about the prognostic independence of LVSI from molecular signature.

Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature